CIK 0001404281 · Non-accelerated filer<br>Smaller reporting company
Eledon Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 949-238-8090
- Business address
- 19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-02 | OrbiMed Israel GP Ltd. 10% owner | Sale | −103,200 | $21.60 | $2.2M | 73,650 |
| 2020-10-30 | Logos Global Management LP 10% owner | Sale | −12,942 | $26.64 | $345K | 187,058 |
| 2020-10-30 | Logos Global Management LP 10% owner | Sale | −27 | $27.02 | $730 | 199,973 |
| 2019-05-21 | TURKEL CATHERINE C. President | Sale | −1,914 | $1.91 | $4K | 88,662 |
| 2019-05-21 | Kuwahara Jon See Remarks | Sale | −1,058 | $1.91 | $2K | 5,974 |
| 2019-05-21 | FLESHER GREGORY J. Chief Executive Officer | Sale | −2,937 | $1.91 | $6K | 156,918 |
| 2019-05-20 | TURKEL CATHERINE C. President | Sale | −7,623 | $1.96 | $15K | 90,576 |
| 2019-05-20 | Kuwahara Jon See Remarks | Sale | −4,218 | $1.96 | $8K | 7,032 |
| 2019-05-20 | FLESHER GREGORY J. Chief Executive Officer | Sale | −11,701 | $1.96 | $23K | 159,855 |
| 2019-04-30 | LIFESCI INDEX PARTNERS LLC 10% owner | Sale | −200 | $2.70 | $540 | 1,065,867 |
| 2015-09-21 | McBride John S. Chief Operating Officer | Sale | −13,500 | $14.01 | $189K | 0 |
| 2015-09-08 | Kalowski Lee Chief Financial Officer | Sale | −4,668 | $13.13 | $61K | 40,953 |
| 2015-09-02 | Kalowski Lee Chief Financial Officer | Sale | −2,158 | $12.96 | $28K | 45,621 |
| 2015-07-29 | Morrison Jodie Pope President and CEO | Sale | −564 | $13.70 | $8K | 19,551 |
| 2015-07-28 | Morrison Jodie Pope President and CEO | Sale | −12,000 | $13.70 | $164K | 19,551 |
| 2015-07-15 | Novartis Bioventures Ltd 10% owner | Sale | −3,566 | $14.26 | $51K | 4,493,458 |
| 2015-07-14 | Novartis Bioventures Ltd 10% owner | Sale | −27,861 | $14.41 | $401K | 4,497,024 |
| 2015-07-13 | Novartis Bioventures Ltd 10% owner | Sale | −20,611 | $14.20 | $293K | 4,524,885 |
| 2015-06-29 | Morrison Jodie Pope President and CEO | Sale | −8,000 | $13.70 | $110K | 9,551 |
| 2015-06-26 | Morrison Jodie Pope President and CEO | Sale | −8,000 | $13.83 | $111K | 9,551 |
Page 1 of 2 · 31 trades